Literature DB >> 24450664

Imaging of breast cancer-related changes after surgical therapy.

Colleen H Neal1, Zeynep N Yilmaz, Mitra Noroozian, Katherine A Klein, Baskaran Sundaram, Ella A Kazerooni, Jadranka Stojanovska.   

Abstract

OBJECTIVE: The purpose of this article is to discuss the surgical treatment of breast cancer and its resultant thoracic CT and multimodality imaging manifestations.
CONCLUSION: Many breast cancer patients undergo cross-sectional imaging at some point during or after treatment. Thoracic CT is an important modality performed for staging and surveillance. Thoracic CT examinations often show findings related to patients' surgical or adjuvant treatment. The postsurgical changes visible on thoracic CT may include those related to lumpectomy, mastectomy, breast reconstruction, and axillary surgery. Postsurgical complications may also be seen, including fluid collections, infection, fat necrosis, and lymphedema. Recognition and appropriate interpretation of the posttherapeutic spectrum of findings are important to avoid unnecessary diagnostic imaging and minimize patient anxiety.

Entities:  

Mesh:

Year:  2014        PMID: 24450664     DOI: 10.2214/AJR.13.11517

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

Review 1.  A pictorial review: multimodality imaging of benign and suspicious features of fat necrosis in the breast.

Authors:  Sidra J Tayyab; Beatriz E Adrada; Gaiane Margishvili Rauch; Wei Tse Yang
Journal:  Br J Radiol       Date:  2018-07-31       Impact factor: 3.039

Review 2.  Intramammary Findings on CT of the Chest - a Review of Normal Anatomy and Possible Findings.

Authors:  Johannes Gossner
Journal:  Pol J Radiol       Date:  2016-09-02

3.  Ultrasound for postoperative surveillance after mastectomy in patients with breast cancer: A retrospective study.

Authors:  Yu-Qing Liu; Jia-Nan Dong; Qing-Xin Meng; Ping Sun; Jing Zhang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.